INVEST-REGISTRY: Minimally Invasive Endoscopic Surgical Treatment With Apollo/Artemis in Patients With Brain Hemorrhage: A Prospective Multicenter Registry
Objective: The primary objective of this multicenter prospective registry is to provide additional safety, technical outcomes and clinical outcomes data for minimally invasive endoscopic surgery (MIES) with Apollo or Artemis for the evacuation of supratentorial brain hemorrhage in adult patients who do not qualify for the concurrent INVEST Feasibility randomized controlled trial at active INVEST centers.
• Patient age 022 years or older
• Supratentorial brain hemorrhage, which may be:
‣ Intracerebral (ICH)
⁃ Primarily Intracerebral (ICH) with a component of intraventricular hemorrhage (IVH)
⁃ Primarily intraventricular hemorrhage (IVH) with a component of ICH
⁃ Intraventricular hemorrhage (IVH)
• Patient does not qualify for the concurrent INVEST Feasibility study